MedPath

Efficacy Testing of a Culturally Relevant Stigma Intervention With WLWH in Tanzania

Not Applicable
Completed
Conditions
Self Esteem
Hope
Self Efficacy
Depressive Symptoms
HIV
Stigma, Social
Interventions
Behavioral: Labda Siku Moja stigma reduction intervention
Registration Number
NCT05033002
Lead Sponsor
Duke University
Brief Summary

This study will test a stigma reduction intervention with women living with HIV in Tanzania.

Detailed Description

This study will test a culturally and linguistically relevant stigma reduction intervention, Labda Siku Moja, among women living with HIV in Tanzania.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
167
Inclusion Criteria

The inclusion criteria for this study are:

  • (1) women who are living with HIV;
  • (2) age 18 (age of adulthood as defined by the Tanzanian government);
  • (3) able and willing to voluntarily consent to participate in the study;
  • (4) able to travel to a data collection in their local community (as described above);
  • (5) demonstrate mental competence at time of informed consent;
  • (6) verbally indicate that they plan to reside in their current community for at least 6 months after enrollment (necessary to prevent attrition);
  • (7) score at the median or higher level on the Swahili Version of the Multidimensional Measure of Internalized HIV Stigma Scale.
Read More
Exclusion Criteria
  • (1) any acute psychological or physiological distress; if there is evidence of acute psychologic and/or physiologic, they will be excluded from this study and referred to an appropriate site for evaluation and treatment.
  • (2) Transgender women living with HIV will not be eligible to participate in this study to reduce the potential for confounding sources of stigma recognizing that a transgender identity is highly stigmatized and culturally sensitive in Tanzania. Further, it would be exceedingly difficult to recruit a sufficient sample of transgender women living with HIV to conduct an appropriate analysis.
  • (3) Participants may be enrolled in other HIV-related studies except cognitive-behavioral intervention studies addressing stigma, self-efficacy, self-esteem, and/or disclosure
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Stigma Intervention GroupLabda Siku Moja stigma reduction interventionThis group will participate in a 5 week intervention. Each week, intervention group participants will watch one ethnodrama segment of the Labda Siku Moja stigma reduction intervention followed by a guided debrief using motivational interviewing.
Primary Outcome Measures
NameTimeMethod
Percent of questions left blank on study instrumentsup to 180 days
Number of study participants retained in study as measured by enrollment logsup to 180 days
Number of participants recruited as measured by enrollment logsup to 6 months
Number of women who completed all 5 sessionsup to 10 weeks after enrollment
Secondary Outcome Measures
NameTimeMethod
change in coping self-efficacy, as measured by the Swahili version of the Coping Self-Efficacy Scalebaseline and 30, 90, and 180 days after intervention

Scores range from 0 to 26, with lower scores indicating lower coping self-efficacy and higher scores indicating greater coping self-efficacy.

change in self-esteem, as measured by the Swahili version of the Rosenberg Self-Esteem Scalebaseline and 30, 90, and 180 days after intervention

Scores range from 10 to 40, with lower scores indicating lower self-esteem and higher scores indicating higher self-esteem

change in internalized stigma, as measured by the Swahili version of the Multidimensional Measure of Internalized Stigma Scalebaseline and 30, 90, and 180 days after intervention

Scores range from 0 to 100 with lower scores indicating less stigma and higher scores indicating more stigma

change in depressive symptoms, as measured by the Swahili version of the Patient Health Questionnaire 9baseline and 30, 90, and 180 days after intervention

Scores range from 0 to 27, with lower scores indicating less depressive symptoms and higher scores indicating more depressive symptoms

change in hope, as measured by the Swahili version of the State of Hope Scalebaseline and 30, 90, and 180 days after intervention

Scores range from 6 to 24, with lower scores indicating less hope and higher scores indicating more hope

Trial Locations

Locations (1)

Muhimbili University of Health and Allied Sciences

🇹🇿

Dar Es Salaam, Tanzania

© Copyright 2025. All Rights Reserved by MedPath